ERBB2 and gastric cancer: In addition, GC is a highly heterogeneous tumor, and HER2 positivity is found in only approximately 13.0%–22.0% of GC cases (Cappellesso et al., 2015; Van Cutsem et al., 2015; Abrahao-Machado and Scapulatempo-Neto, 2016).